Table 1 Baseline characteristics of incident dialysis patients with and without MPI screening
From: Coronary artery disease screening and prognosis in incident dialysis patients
MPI screening | |||
|---|---|---|---|
Yes | No | p | |
n = 164 | n = 60 | ||
Age (years) | 64 ± 12 | 66 ± 17 | 0.350 |
Male (%) | 67 | 55 | 0.097 |
BMI (kg/m2) | 22 ± 3 | 22 ± 3 | 0.170 |
Diabetes (%) | 55 | 37 | 0.016 |
SBP (mmHg) | 154 ± 23 | 147 ± 30 | 0.069 |
DBP (mmHg) | 78 ± 16 | 72 ± 11 | 0.014 |
Ejection fraction (%) | 67 ± 9 | 66 ± 9 | 0.403 |
Albumin (g/dL) | 3.3 ± 0.5 | 3.3 ± 0.5 | 0.525 |
Hemoglobin (g/dL) | 8.1 ± 1.5 | 8.4 ± 1.6 | 0.260 |
Total cholesterol (mg/dL) | 175 ± 53 | 177 ± 55 | 0.828 |
Triglyceride (mg/dL) | 123 ± 72 | 132 ± 61 | 0.378 |
HDL-C (mg/dL) | 50 ± 17 | 46 ± 15 | 0.172 |
Creatinin (mg/dL) | 9.8 ± 3.5 | 8.6 ± 3.9 | 0.037 |
eGFR (mL/min/1.73 m2) | 5.0 ± 1.7 | 5.8 ± 2.3 | 0.007 |
cCa (mg/dL) | 8.0 ± 1.0 | 8.2 ± 0.9 | 0.107 |
P (mg/dL) | 6.2 ± 1.7 | 5.8 ± 1.6 | 0.082 |
iPTH (pg/mL) | 338 ± 315 | 302 ± 170 | 0.396 |
CRP (mg/dL) (IQR) | 0.1 | 0.15 | 0.154 |
Statin (%) | 18 | 19 | 0.953 |
RAS inhibitor (%) | 66 | 53 | 0.071 |
Beta blocker (%) | 23 | 17 | 0.321 |
Coronary artery disease (%) | 27 (16.5) | ||
CRT (%) | 9 (5.5) | ||